These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11231045)

  • 1. A molecular modeling and 3D QSAR study of a large series of indole inhibitors of human non-pancreatic secretory phospholipase A2.
    Bernard P; Pintore M; Berthon JY; Chrétien JR
    Eur J Med Chem; 2001 Jan; 36(1):1-19. PubMed ID: 11231045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein-based alignment in 3D QSAR of 26 indole inhibitors of human pancreatic phospholipase A2.
    Pintore M; Bernard P; Berthon JY; Chrétien JR
    Eur J Med Chem; 2001 Jan; 36(1):21-30. PubMed ID: 11231046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular docking and 3D-QSAR CoMFA studies on indole inhibitors of GIIA secreted phospholipase A(2).
    Mouchlis VD; Mavromoustakos TM; Kokotos G
    J Chem Inf Model; 2010 Sep; 50(9):1589-601. PubMed ID: 20795712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based design of the first potent and selective inhibitor of human non-pancreatic secretory phospholipase A2.
    Schevitz RW; Bach NJ; Carlson DG; Chirgadze NY; Clawson DK; Dillard RD; Draheim SE; Hartley LW; Jones ND; Mihelich ED
    Nat Struct Biol; 1995 Jun; 2(6):458-65. PubMed ID: 7664108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative structure-activity relationship (QSAR) analysis of a series of indole analogues as inhibitor for human group V secretory phospholipase A2.
    OmPraba G; Velmurugan D
    Indian J Biochem Biophys; 2006 Jun; 43(3):154-9. PubMed ID: 16967904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indole inhibitors of human nonpancreatic secretory phospholipase A2. 1. Indole-3-acetamides.
    Dillard RD; Bach NJ; Draheim SE; Berry DR; Carlson DG; Chirgadze NY; Clawson DK; Hartley LW; Johnson LM; Jones ND; McKinney ER; Mihelich ED; Olkowski JL; Schevitz RW; Smith AC; Snyder DW; Sommers CD; Wery JP
    J Med Chem; 1996 Dec; 39(26):5119-36. PubMed ID: 9005255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbocyclic[g]indole inhibitors of human nonpancreatic s-PLA2.
    Sawyer JS; Beight DW; Smith EC; Snyder DW; Chastain MK; Tielking RL; Hartley LW; Carlson DG
    J Med Chem; 2005 Feb; 48(3):893-6. PubMed ID: 15689175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory mode of indole-2-carboxamide derivatives against HLGPa: molecular docking and 3D-QSAR analyses.
    Liu G; Zhang Z; Luo X; Shen J; Liu H; Shen X; Chen K; Jiang H
    Bioorg Med Chem; 2004 Aug; 12(15):4147-57. PubMed ID: 15246091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-affinity aptamers selectively inhibit human nonpancreatic secretory phospholipase A2 (hnps-PLA2).
    Bridonneau P; Chang YF; O'Connell D; Gill SC; Snyder DW; Johnson L; Goodson T; Herron DK; Parma DH
    J Med Chem; 1998 Mar; 41(6):778-86. PubMed ID: 9526554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indole inhibitors of human nonpancreatic secretory phospholipase A2. 3. Indole-3-glyoxamides.
    Draheim SE; Bach NJ; Dillard RD; Berry DR; Carlson DG; Chirgadze NY; Clawson DK; Hartley LW; Johnson LM; Jones ND; McKinney ER; Mihelich ED; Olkowski JL; Schevitz RW; Smith AC; Snyder DW; Sommers CD; Wery JP
    J Med Chem; 1996 Dec; 39(26):5159-75. PubMed ID: 8978844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indole inhibitors of human nonpancreatic secretory phospholipase A2. 2. Indole-3-acetamides with additional functionality.
    Dillard RD; Bach NJ; Draheim SE; Berry DR; Carlson DG; Chirgadze NY; Clawson DK; Hartley LW; Johnson LM; Jones ND; McKinney ER; Mihelich ED; Olkowski JL; Schevitz RW; Smith AC; Snyder DW; Sommers CD; Wery JP
    J Med Chem; 1996 Dec; 39(26):5137-58. PubMed ID: 8978843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploration of a binding mode of indole amide analogues as potent histone deacetylase inhibitors and 3D-QSAR analyses.
    Guo Y; Xiao J; Guo Z; Chu F; Cheng Y; Wu S
    Bioorg Med Chem; 2005 Sep; 13(18):5424-34. PubMed ID: 15963726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reliability of comparative molecular field analysis models: effects of data scaling and variable selection using a set of human synovial fluid phospholipase A2 inhibitors.
    Ortiz AR; Pastor M; Palomer A; Cruciani G; Gago F; Wade RC
    J Med Chem; 1997 Mar; 40(7):1136-48. PubMed ID: 9089335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemically induced dimerization of human nonpancreatic secretory phospholipase A2 by bis-indole derivatives.
    Zhou L; Fang C; Wei P; Liu S; Liu Y; Lai L
    J Med Chem; 2008 Jun; 51(12):3360-6. PubMed ID: 18522384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies.
    Hou T; Zhu L; Chen L; Xu X
    J Chem Inf Comput Sci; 2003; 43(1):273-87. PubMed ID: 12546563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined 3D-QSAR modeling and molecular docking study on indolinone derivatives as inhibitors of 3-phosphoinositide-dependent protein kinase-1.
    AbdulHameed MD; Hamza A; Liu J; Zhan CG
    J Chem Inf Model; 2008 Sep; 48(9):1760-72. PubMed ID: 18717540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationships of indole cytosolic phospholipase A(2)alpha inhibitors: substrate mimetics.
    McKew JC; Lovering F; Clark JD; Bemis J; Xiang Y; Shen M; Zhang W; Alvarez JC; Joseph-McCarthy D
    Bioorg Med Chem Lett; 2003 Dec; 13(24):4501-4. PubMed ID: 14643356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the Structural Features of Guanine Derivatives as MGMT Inhibitors Using 3D-QSAR Modeling Combined with Molecular Docking.
    Sun G; Fan T; Zhang N; Ren T; Zhao L; Zhong R
    Molecules; 2016 Jun; 21(7):. PubMed ID: 27347909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of benzoyl phenyl benzoates as effective inhibitors for phospholipase A2 and hyaluronidase enzymes.
    Khanum SA; Murari SK; Vishwanth BS; Shashikanth S
    Bioorg Med Chem Lett; 2005 Sep; 15(18):4100-4. PubMed ID: 15993585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based design of a new class of anti-inflammatory drugs: secretory phospholipase A(2) inhibitors, SPI.
    Mihelich ED; Schevitz RW
    Biochim Biophys Acta; 1999 Nov; 1441(2-3):223-8. PubMed ID: 10570250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.